Prediction of radiation pneumonitis following high-dose thoracic radiation therapy by 3 gy/fraction for non-small cell lung cancer: Analysis of clinical and dosimetric factors

Japanese Journal of Clinical Oncology

Volumn 39, Issue 3, 2009, Pages 151-157

  Oh, Dongryul ^a   Ahn, Yong Chan ^a   Park, Hee Chul ^a   Lim, Do Hoon ^a   Han, Youngyih ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Hypofractionated treatment; Lung cancer; Radiation pneumonitis; Radiation therapy

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER RISK; CANCER STAGING; CLINICAL STUDY; CONTROLLED STUDY; DOSIMETRY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INCIDENCE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTION; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; RECEIVER OPERATING CHARACTERISTIC; TUMOR LOCALIZATION; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PNEUMONIA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOTHERAPY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE;

EID: 61449223627     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyn158     Document Type: Article

References (20)

1. Lester JF, Macbeth FR, Brewster AE, Court JB, Iqbal N. CT-planned accelerated hypofractionated radiotherapy in the radical treatment of non-small cell lung cancer. Lung Cancer 2004;45:237-42.
2. Price A. Results of a survey of UK Clinical Oncologists; 2001.
3. Kim B, Ahn YC, Lim do H, Nam HR. High-dose thoracic radiation therapy at 3.0 Gy/fraction in inoperable stage I/II non-small cell lung cancer. Jpn J Clin Oncol 2008;38:92-8.
4. Clenton SJ, Fisher PM, Conway J, Kirkbride P, Hatton MQ. The use of lung dose-volume histograms in predicting post-radiation pneumonitis after non-conventionally fractionated radiotherapy for thoracic carcinoma. Clin Oncol (R Coll Radiol) 2005;17:599-603.
5. Fay M, Tan A, Fisher R, Mac Manus M, Wirth A, Ball D. Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 2005;61:1355-63.
6. Hernando ML, Marks LB, Bentel GC, Zhou SM, Hollis D, Das SK, et al. Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 2001;51:650-9.
7. Kim TH, Cho KH, Pyo HR, Lee JS, Zo JI, Lee DH, et al. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Radiology 2005;235:208-15.
8. Rancati T, Ceresoli GL, Gagliardi G, Schipani S, Cattaneo GM. Factors predicting radiation pneumonitis in lung cancer patients: A retrospective study. Radiother Oncol 2003;67:275-83.
9. Schallenkamp JM, Miller RC, Brinkmann DH, Foote T, Garces YI. Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates. Int J Radiat Oncol Biol Phys 2007;67:410-6.
10. Thirion P, Holmberg O, Collins CD, O'shea C, Moriarty M, Pomeroy M, et al. Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy. Radiother Oncol 2004;71:163-6.
11. Tsujino K, Hirota S, Kotani Y, Kado T, Yoden E, Fujii O, et al. Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: Dose-volume histogram analysis and comparison with conventional chemoradiation. Int J Radiat Oncol Biol Phys 2006;64:1100-5.
12. Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu CS, et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 2006;66:1399-407.
13. Robnett TJ, Machtay M, Vines EF, McKenna MG, Algazy KM, McKenna WG. Factors predicting severe radiation pneumonitis in patients receiving de.nitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 2000;48:89-94.
14. Yamada M, Kudoh S, Hirata K, Nakajima T, Yoshikawa J. Risk factors of pneumonitis following chemoradiotherapy for lung cancer. Eur J Cancer 1998;34:71-5.
15. Armstrong J, McGibney C. The impact of three-dimensional radiation on the treatment of non-small cell lung cancer. Radiother Oncol 2000;56:157-67.
16. Graham MV, Purdy JA, Emami B, Harms W, Bosch W, Lockett MA, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999;45:323-9.
17. Rodrigues GB. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: Clinical and dosimetric factors analysis. Radiother Oncol 2005;75:120-1.
18. Yorke ED, Jackson A, Rosenzweig KE, Braban L, Leibel SA, Ling CC. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 2005;63:672-82.
19. Pirtoli L, Bindi M, Bellezza A, Pepi F, Tucci E. Unfavorable experience with hypofractionated radiotherapy in unresectable lung cancer. Tumori 1992;78:305-10.
20. Roach M 3rd, Gandara DR, Yuo HS, Swift PS, Kroll S, Shrieve DC, et al. Radiation pneumonitis following combined modality therapy for lung cancer: Analysis of prognostic factors. J Clin Oncol 1995;13:2606-12.